AbCellera to Present at Upcoming Investor Conferences in November

Rhea-AI Summary

AbCellera (Nasdaq: ABCL) announced participation in two major investor conferences. The company will present at the Credit Suisse 31st Annual Healthcare Conference on November 9, 2022, at 3:50 p.m. PT, and at the Stifel 2022 Healthcare Conference on November 15, 2022, at 8:30 a.m. PT. Live webcasts will be available on AbCellera's Investor Relations website, with replays following the events. AbCellera is focused on leveraging natural immune systems to discover antibodies for drug development.

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the following investor conferences:

• Credit Suisse 31st Annual Healthcare Conference on Wednesday, November 9, 2022, at 3:50 p.m. Pacific Time (6:50 p.m. Eastern Time)
• Stifel 2022 Healthcare Conference on Tuesday, November 15, 2022, at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time)

Live audio webcasts of each presentation may be accessed through links that will be posted on AbCellera's Investor Relations website. Replays of each webcast will be available through the same links following the presentations.

About AbCellera Biologics Inc.
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.

Source: AbCellera Biologics Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221104005586/en/

Inquiries

Media: Jessica Yingling, Ph.D.; media@abcellera.com, +1(236)521-6774

Business Development: Murray McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005

Investor Relations: Josephine Hellschlienger, Ph.D.; ir@abcellera.com, +1(778)729-9116

Source: AbCellera Biologics Inc.

FAQ

What are the dates of AbCellera's presentations at investor conferences in 2022?

AbCellera will present at the Credit Suisse 31st Annual Healthcare Conference on November 9, 2022, and at the Stifel 2022 Healthcare Conference on November 15, 2022.

What time will AbCellera present at the Credit Suisse conference?

AbCellera's presentation at the Credit Suisse conference is scheduled for 3:50 p.m. Pacific Time on November 9, 2022.

Where can I listen to the live audio webcasts of AbCellera's presentations?

Live audio webcasts of AbCellera's presentations can be accessed through links posted on AbCellera's Investor Relations website.

What is AbCellera's focus in drug development?

AbCellera focuses on searching, decoding, and analyzing natural immune systems to find antibodies for drug development.

What is the stock symbol for AbCellera?

The stock symbol for AbCellera is ABCL.